Fehlerhafte sekretorische Proteine werden über einen speziellen Abbauweg, die ER-assoziierte Proteindegradation (ERAD), mit Lysin48-verknüpften Ubiquitinketten polyubiquitiniert und dem proteolytischen Abbau am 26S Proteasom zugeführt. In der Hefe Saccharomyces cerevisiae bilden die beiden ER-membranständigen RING-Ubiquitinligasen Hrd1 und Doa10 zentrale Komponenten im Ubiquitinierungsprozess. Das lösliche zytosolische Ubiquitin-konjugierende Enzym Ubc7, welches mit beiden Ligasen bei der Polyubiquitinierung von Substratproteinen zusammenwirkt, wird über den membranverankerten Co-Faktor Cue1 an die ER-Membran rekrutiert. Die in dieser Arbeit dargestellten Ergebnisse belegen zwei weitere Funktionen für Cue1 im Ubiquitinierungsprozess: Die Bindung von Ubc7 an einen carboxyterminalen Bereich in Cue1 führt zur Stimulation der Ubiquitinierungsaktivität von Ubc7 mit den RING-Ligasen. Darüber hinaus bewirkt die Ubiquitin-bindende CUE-Domäne in Cue1 eine Steigerung der Länge der Ubiquitinketten und deren Syntheserate, was zum effektiven Abbau einiger ER-membrangebundener Substratproteine beiträgt. Die durch Ubc7 synthetisierten Lysin48-verknüpften Ubiquitinketten werden in Abhängigkeit eines schleifenförmigen sauren Bereichs in Ubc7 gebildet. Entfernen dieses Bereichs resultiert im Abbruch der Ubiquitinierung nach Konjugation eines Monoubiquitins auf dem Substrat. An der Hrd1-Ligase werden durch Ubc7 polyubiquitinierte Proteine umgehend zum Proteasom transferiert. Für den Doa10-abhängigen Substratabbau ist die Funktion eines weiteren Ubiquitin-konjugierenden Enzyms, Ubc6, notwendig. Die hier gezeigten Daten weisen auf eine Ubc6-abhängige Verknüpfung von Ubiquitinmolekülen in einer Lysin11-abhängigen Weise hin. Eine Inhibition der Synthese Lysin11-verknüpfter Ubiquitinketten hatte jedoch keinen Effekt auf den Abbau von Substratproteinen. Stattdessen wurde der Abbau von Ubc6 selbst durch Unterbindung der Bildung Lysin27-verknüpfter Ubiquitinketten verhindert. / Aberrant secretory proteins are removed from the cell in a process termed „endoplasmic reticulum-associated protein degradation" (ERAD), as it screens the endoplasmic reticulum for unwanted polypeptides and triggers their elimination via the 26S proteasome. To this end, client proteins of the ERAD pathway are polyubiquitinated with lysine48-linked ubiquitin chains at the ER membrane. Two ER membrane-integrated RING ubiquitin ligases, Hrd1 and Doa10, constitute central components of the ubiquitination machinery in Saccharomyces cerevisiae. To polyubiquitinate substrate proteins, both ligases interact with the ubiquitin-conjugating enzyme Ubc7. Since Ubc7 itself is a soluble cytosolic protein, it is recruited to the ER-membrane by is anchoring factor Cue1. Results in this study reveal two additional functions of Cue1 in the ubiquitination reaction: First, binding of Ubc7 to the Cue1-carboxyterminus stimulates the ubiquitin chain formation by Ubc7 and the ligases. Second, the CUE domain within Cue1 increases the chain length and accelerates the synthesis of the polyubiquitin chain, which results in efficient degradation of certain substrate proteins. Formation of lysine48-linked ubiquitin chains by Ubc7 depends on an acidic loop within Ubc7. Deletion of this structure leads to inhibition of ubiquitin chain elongation after the initial substrate monoubiquitination. Client proteins, ubiquitinated by Ubc7 and Hrd1, are immediately transferred to the proteasome. For Doa10-dependent substrate degradation, the activity of another ubiquitin-conjugating enzyme, Ubc6, is required. Data shown here indicate a function of Ubc6 in the formation of lysine11-linked polyubiquitin, since mutation of this lysine residue resulted in the prevention of ubiquitin chain synthesis. However, expression of this ubiquitin mutant had no effect on substrate degradation. Moreover, the proteolysis of Ubc6 itself is inhibited by prevention of lysin27-linked polyubiquitin chain formation.

Ubiquitination is a post-translational modification that can take several forms. Some proteins are modified with a single ubiquitin molecule, while others are modified with polyubiquitin chains. Each type of ubiquitination is thought to have distinct biological functions. The best-characterized types of ubiquitin modification are K48-linked polyubiquitination, which serves as a signal for proteasomal degradation and K63-linked polyubiquitination, which has non-proteolytic functions such in DNA repair, signaling, and endocytosis. HECT ubiquitin ligases (HECT E3s) form a class of E3s, defined by a C terminal catalytic domain. Several lines of evidence suggested that the HECT E3s assemble a polyubiquitin chain in a sequential manner with one molecule of ubiquitin at a time being conjugated to the distal ubiquitin of the chain. In the process of chain elongation, not all HECT E3s target a common internal lysine of ubiquitin, leading to diversification of chain type specificity in HECT E3s. For example, yeast Rsp5 forms K63 chains, while human E6AP forms K48 chains. Two important mechanistic questions were addressed in my work: 1) what are the determinants of chain type specificity of HECT E3s, and 2) what allows the distal ubiquitin of a chain to be continuously oriented near the active site of the HECT domain in the course of a sequential polyubiquitination reaction? I have determined that the chain type specificity of Rsp5 is a function solely of the HECT domain. Further, through the generation of chimeric HECT E3s, I demonstrated that chain type specificity determinants are located within the last 60 amino acids of the C lobe of the HECT domain. To address the second question, we solved the structure of Rsp5 HECT domain in complex with non-covalently bound ubiquitin in collaboration with Jue Chen’s laboratory (Purdue University). From the structure, we found that the N lobe of the HECT domain binds ubiquitin in a manner distinct from other known ubiquitin binding domains, and I have shown that Rsp5 proteins defective for ubiquitin binding are defective for chain elongation. We hypothesize that the ubiquitin binding site functions in the recruitment of the distal ubiquitin of polyubiquitin chain for efficient polyubiquitination. / text

Managed Pressure Drilling now at the pinnacle of the 'Oil Well Drilling' evolution tree, has itself been coined in 2003. It is an umbrella term for a few new drilling techniques and some preexisting drilling techniques, all of them aiming to solve several drilling problems, including non-productive time and/or drilling flat time issues. These techniques, now sub-classifications of Managed Pressure Drilling, are referred to as 'Variations' and 'Methods' of Managed Pressure Drilling. Although using Managed Pressure Drilling for drilling wells has several benefits, not all wells that seem a potential candidate for Managed Pressure Drilling, need Managed Pressure Drilling. The drilling industry has numerous simulators and software models to perform drilling hydraulics calculations and simulations. Most of them are designed for conventional well hydraulics, while some can perform Underbalanced Drilling calculations, and a select few can perform Managed Pressure Drilling calculations. Most of the few available Managed Pressure Drilling models are modified Underbalanced Drilling versions that fit Managed Pressure Drilling needs. However, none of them focus on Managed Pressure Drilling and its candidate selection alone. An 'Managed Pressure Drilling Candidate Selection Model and software' that can act as a preliminary screen to determine the utility of Managed Pressure Drilling for potential candidate wells are developed as a part of this research dissertation. The model and a flow diagram identify the key steps in candidate selection. The software performs the basic hydraulic calculations and provides useful results in the form of tables, plots and graphs that would help in making better engineering decisions. An additional Managed Pressure Drilling worldwide wells database with basic information on a few Managed Pressure Drilling projects has also been compiled that can act as a basic guide on the Managed Pressure Drilling variation and project frequencies and aid in Managed Pressure Drilling candidate selection.

Les domaines de transactivation (TAD) acides sont présents dans plusieurs protéines oncogéniques, virales et dans des facteurs de différenciation de cellules souches. Ces domaines acides contrôlent la transcription à travers une myriade d’interactions avec divers partenaires ce qui provoque l’activation de la transcription ou leur propre élimination. Cependant, dans la dernière décennie, de plus en plus de recherches ont démontré que les TAD possédaient un sous-domaine activation/dégradation (DAD) responsable pour une fonction d'activation de la transcription dépendante de la dégradation de la protéine. Un tel phénomène peut être accompli par plusieurs moyens tels que des modifications post-traductionnelles, l’association à des cofacteurs ou la formation d’un réseau d’interaction complexe en chaînes. Or, aucune preuve concrète n’a pu clairement démontrer le fonctionnement de la dépendance paradoxale entre ces deux fonctions sur un activateur de transcription. Le DAD, a été observé dans plusieurs facteurs de transcription incluant la protéine suppresseur de tumeur p53 et le facteur de différenciation érythrocyte EKLF. Un aspect particulier des DAD est que la composition de leur séquence d’acide aminé est fortement similaire à celle des domaines de liaison à l’ubiquitine (UBD) qui jouent un rôle clé dans le contrôle de la transcription à travers leur interaction non-covalente avec l’ubiquitine. Ainsi, dans ce mémoire, nous avons étudié la possibilité que les TAD acides soient capables d’agir comme UBD pour réguler leur fonction paradoxale à travers des interactions non-covalentes avec l’ubiquitine. L’analyse est faite en utilisant la résonnance magnétique nucléaire (RMN) ainsi qu’avec des essais fonctionnels de dégradation. En somme, cette étude amène une plus grande compréhension des protéines impliquées dans le contrôle des TAD et caractérise le tout premier exemple de TAD capable d’interagir avec l’ubiquitine. / Acidic transactivating domains have been shown to be potential targets for a number of different therapies but their dynamic nature and their ability to bind many interacting partners has made it difficult to fully understand their functioning mechanisms. What we do know about these domains is that they readily control transcription through a myriad of interactions capable of either activating specific aspects of their function or simply, signal for their own demise. Within the acidic TADs lies an unusual degradation/activation domain (DAD) capable of activating transcription at the cost of its degradation. In other words, DAD transcriptional activation is dependent on the degradation of the protein. Such a phenomenon could be explained by a wide variety of hypotheses like the play of post-translational modifications, co-factors, or maybe just a really sophisticated time scaled network of interactions. However, no concrete explanation of how this dual dependent functioning domain works has yet to surface. The DAD has been observed within acidic TADs of several transcription factors including the tumor suppressor p53 and the red blood cell differentiation factor EKLF. Interestingly though, the amino acid sequence composition of DADs share a strong similarity with several types of sequences from domains that bind ubiquitin (UBDs). These domains have been shown in the past to, in addition to their role in degradation, play a key role in regulating transcription through non-covalent interaction with ubiquitin. Hence, in this project, we investigated weather acidic TADs had the ability to function as UBDs and form non-covalent interactions with ubiquitin and also to determine the functional significance of this interaction in regards to the dual function of acidic TADs.